009290 — Kwangdong Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩261bn
- KR₩356bn
- KR₩2tn
- 56
- 90
- 54
- 79
Annual cashflow statement for Kwangdong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 22,656 | 45,602 | 25,541 | 26,701 | 39,372 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 30,109 | 15,824 | 30,609 | 30,761 | 18,340 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -42,216 | -58,235 | -15,248 | -8,588 | -82,278 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 29,285 | 22,829 | 54,940 | 62,822 | -11,730 |
Capital Expenditures | -12,682 | -5,303 | -24,447 | -26,039 | -35,158 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -5,107 | -42,257 | -18,529 | -16,707 | -36,673 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17,790 | -47,560 | -42,976 | -42,747 | -71,831 |
Financing Cash Flow Items | -224 | — | -85.5 | -10.5 | 1,010 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,205 | 3,838 | 15,894 | -628 | 58,010 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8,798 | -21,399 | 29,084 | 19,587 | -26,208 |